Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study

D. Price (Singapore, Singapore), J. Voorham (Singapore, Singapore), G. Brusselle (Ghent, Belgium), A. Clemens (Basel, Switzerland), R. Fogel (East Hanover, United States of America), H. Park (Seoul, Republic of Korea), J. Stephens (Wales, United Kingdom), N. Roche (Paris, France)

Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Session: Interdependence of COPD and comorbidities and the underlying mechanisms
Session type: Poster Discussion
Number: 3621
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Price (Singapore, Singapore), J. Voorham (Singapore, Singapore), G. Brusselle (Ghent, Belgium), A. Clemens (Basel, Switzerland), R. Fogel (East Hanover, United States of America), H. Park (Seoul, Republic of Korea), J. Stephens (Wales, United Kingdom), N. Roche (Paris, France). Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study. 3621

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020
Year: 2021



Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018


Determinants of incident asthma-COPD overlap compared to asthma and COPD alone: A prospective study of 55,110 middle-aged adults
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017



Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Risk of stroke in COPD: a matched cohort study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Impact of chronic cough in individuals with COPD: a population-based cohort study
Source: International Congress 2019 – More and more COPD
Year: 2019


Patients eligible for anti-IL-5/anti-IL-5Ra treatment in a cohort of adult-onset asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018


Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017


Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Non-adherence and sub-optimal treatment with asthma medications in young adults: a population-based cohort study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021


Prognosis of COPD according to exacerbation history: a population-based cohort study
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017


Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study
Source: Annual Congress 2010 - Management of airway disease
Year: 2010


Lung function and reported dyspnea in Greek COPD patients under treatment with fluticasone/salmeterol FDC via Elpenhaler device with or without cardiovascular comorbidity - AEOLOS study.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020



Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008